Latest filing published 03 Jun 2015 for Axogen, Inc., €274.
Insider track record
No signal scores available.
Closed purchases
Based on 11 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +84.5%Entry US$3.16 · Close at T+365 US$5.83
- +55.1%Entry US$3.16 · Close at T+365 US$4.90
- +13.9%Entry US$2.80 · Close at T+365 US$3.19
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lee Robert Johnston Jr.: trading record in brief
This profile gathers the share dealings of Lee Robert Johnston Jr. across 2 companies, led by Axogen, Inc. and RTI Surgical, Inc. Between 30 October 2008 and 2 June 2015, the trades on record add up to 13 filings.
No open-market sale appears; the market trades are 13 purchases worth €94k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2015: 4 purchases and no sales on the market.
In size, the median ticket on the buying side is €3,173. For 11 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 45% of cases, with a median move of -12.9%. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 3 June 2015: an open-market purchase of €274, in Axogen, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lee Robert Johnston Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100 shares@ US$3.05Common StockSEC:0001104659-15-043200:0Canonical exit: 31 Aug 2015 (T+90)
- 4,600 shares@ US$3.06Common StockSEC:0001104659-15-043200:1Canonical exit: 31 Aug 2015 (T+90)
- 200 shares@ US$3.07Common StockSEC:0001104659-15-043200:2Canonical exit: 31 Aug 2015 (T+90)
- 100 shares@ US$3.08Common StockSEC:0001104659-15-043200:3Canonical exit: 31 Aug 2015 (T+90)
- 10,000 shares@ US$3.06Common StockSEC:0001104659-14-086146:0Canonical exit: 10 Mar 2015 (T+90)
- 5,100 shares@ US$2.60Common StockSEC:0001104659-14-045150:0Canonical exit: 4 Sept 2014 (T+90)
- 200 shares@ US$2.59Common StockSEC:0001104659-14-045150:1Canonical exit: 4 Sept 2014 (T+90)
- 200 shares@ US$2.57Common StockSEC:0001104659-14-045150:2Canonical exit: 4 Sept 2014 (T+90)
- 2,600 shares@ US$2.55Common StockSEC:0001104659-14-045150:3Canonical exit: 4 Sept 2014 (T+90)
- 1,700 shares@ US$2.55Common StockSEC:0001104659-14-045150:4Canonical exit: 4 Sept 2014 (T+90)
- 200 shares@ US$2.55Common StockSEC:0001104659-14-045150:5Canonical exit: 4 Sept 2014 (T+90)
- 10,000 shares@ US$1.73Common StockSEC:0001181431-08-063655:0Canonical exit: 18 Feb 2009 (T+90)
- 10,000 shares@ US$2.91Common StockSEC:0001181431-08-059078:0Canonical exit: 28 Jan 2009 (T+90)
13 of 13 declarations
